Anna Robeva
Impact in
- Physiology top 0.2%
- Adenosine and Purinergic Signaling
- Developmental Neuroscience top 2%
- Neurogenesis and neuroplasticity mechanisms
Papers in
-
- Receptor Mechanisms and Signaling 14
-
- Lung Cancer Treatments and Mutations 14
- Lung Cancer Diagnosis and Treatment 7
- Co-authors
- Joel Linden (11 shared papers)Diane L. Rosin (3 shared papers)Patrice G. Guyenet (1 shared paper)Heidi Taylor (4 shared papers)Amy L. Tucker (4 shared papers)Rüdiger Vallon (3 shared papers)Xiaowei Jin (2 shared papers)Christine E. Bandtlow (1 shared paper)
- Journals
- Annals of Oncology (4 papers)Blood (2 papers)Journal of Pharmacology and Experimental Therapeutics (2 papers)Journal of Thoracic Oncology (2 papers)Biochemical Journal (2 papers)
- Partner nations
- United StatesSwitzerlandGermany
In The Last Decade
Anna Robeva
38 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 97
- Physiology 739
- Developmental Neuroscience 181
- Cellular and Molecular Neuroscience 682
- Endocrine and Autonomic Systems 93
- Neurology 116
Countries citing papers authored by Anna Robeva
This map shows the geographic impact of Anna Robeva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Robeva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Robeva more than expected).
Fields of papers citing papers by Anna Robeva
This network shows the impact of papers produced by Anna Robeva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Robeva. The network helps show where Anna Robeva may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Robeva, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 349 | |
| 2 | 1998 | 349 | |
| 3 | 1993 | 188 | |
| 4 | 2001 | 144 | |
| 5 | 1999 | 110 | |
| 6 | 2007 | 98 | |
| 7 | 2019 | 85 | |
| 8 | 1994 | 83 | |
| 9 | 1996 | 76 | |
| 10 | 1996 | 68 | |
| 11 | 2002 | 51 | |
| 12 | 1992 | 49 | |
| 13 | 1999 | 35 | |
| 14 | 2014 | 33 | |
| 15 | Synthetic and endogenous inhibitors of snake venom metalloproteinases. | 1991 | 28 |
| 16 | 2018 | 27 | |
| 17 | 2008 | 26 | |
| 18 | 2021 | 18 | |
| 19 | 1993 | 17 | |
| 20 | 2020 | 17 |
About Anna Robeva
Anna Robeva is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Physiology, Oncology and Cellular and Molecular Neuroscience, having authored 40 papers that have together received 2.0k indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (14 papers), Lung Cancer Treatments and Mutations (14 papers), Adenosine and Purinergic Signaling (11 papers), Lung Cancer Diagnosis and Treatment (7 papers), Neuropeptides and Animal Physiology (6 papers), Lung Cancer Research Studies (4 papers), Cancer Genomics and Diagnostics (3 papers) and Lymphoma Diagnosis and Treatment (3 papers). The work is most often cited by research in Physiology (739 citations), Developmental Neuroscience (181 citations), Cellular and Molecular Neuroscience (682 citations), Endocrine and Autonomic Systems (93 citations) and Neurology (116 citations). Anna Robeva has collaborated with scholars based in United States, Switzerland and Germany. Frequent co-authors include Joel Linden, Diane L. Rosin, Patrice G. Guyenet, Heidi Taylor, Amy L. Tucker, Rüdiger Vallon, Xiaowei Jin, Christine E. Bandtlow, Marjo Simonen and Armin Buss. Their work appears in journals such as Annals of Oncology, Blood, Journal of Pharmacology and Experimental Therapeutics, Journal of Thoracic Oncology and Biochemical Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.